More than half of us are carriers of chronic herpesvirus infections.

But even though the herpesvirus can infect our nerve cells, it rarely causes serious infection of the brain. Researchers from Aarhus University have now discovered a key element of the explanation.

The researchers have discovered a previously unknown defence mechanism in the body that is the reason why herpes infection causes a serious and potentially fatal brain inflammation in only one out of 250,000 cases. The study has recently been published in the scientific journal Nature.

"The study has exciting perspectives because it gives us a better understanding of how the brain defends itself against viral infections," says Professor Søren Riis Paludan from the Department of Biomedicine at Aarhus University. He is the article’s last author, a Lundbeck Foundation Professor and centre director of the Excellence Centre CiViA.

"We’ve discovered how our body prevents herpesvirus from entering into the brain, even though 50-80% of us are chronically infected with this particular virus. The idea behind CiViA is that we want to understand how the body fights infections without harming itself at the same time. The mechanism we've found doesn't cause inflammatory reactions," he says.

The answer lies in the protective TMEFF1 gene.

The brain uses a novel mechanism to keep the virus out

Many years of experimenting with the genome-wide CRISPR screening technology and development of mice that lacked the critical gene have finally convinced the researchers that TMEFF1 produces a protein that prevents herpesvirus from entering into nerve cells.   

The study in Nature is accompanied by another article describing two patients with brain inflammation caused by herpesvirus infection, called herpes encephalitic. In a collaborative study led by researchers in New York, the research group in Aarhus discovered that two children who developed herpes encephalitis were carrying a genetic defect that disabled the protective TMEFF1 gene.

"The new study is groundbreaking because it updates the basic understanding of immunity against viral infections," explains Søren Riis Paludan.

 "This is interesting for immunologists because it illustrates that there are still many immunological mechanisms in the brain that we don’t know about. "The study is also relevant for neuroscience because it sheds light on how the brain, so to say, prevents unwanted visitors from intruding without causing harm to the brain itself, i.e. the neuronal cells," he says.

May provide a better understanding of Alzheimer's

Søren Riis Paludan hopes that the study is the first step towards revealing a completely new range of brain defence mechanisms. One of the tracks that the researchers will now investigate is what the discovery may mean for the development of dementia.

Research has already demonstrated a correlation between infection with herpesviruses and later development of Alzheimer's disease.

"Perhaps our discovery of a new antiviral mechanism in the brain can help to clarify whether individual differences in this particular mechanism or similar mechanisms can give the virus access to the brain and accelerate neurodegenerative processes," says Søren Riis Paludan.

About CiViA

• The Center for Immunology of Viral infections (CiViA) was established in 2023 and is located at the Department of Biomedicine at Aarhus University.
• The centre consists of research groups based at AU and the Technical University Munich. The research groups aim to uncover novel immune mechanisms that contribute to the early defence against infections – and to decipher how the delicate balance between protective and pathological immune responses are achieved.
• Professor Søren Riis Paludan is the centre director of CiViA, which is funded by the Danish National Research Foundation through their Center of Excellence programme.
• Read more here: https://biomed.au.dk/civia

The research results - more information

• The study is basic research.
• The partners are: Mark Denham, Dandrite University; Poul Nissen, AU; Trine Hyrup Mogensen, AU; Jacob Giehm Mikkelsen, AU; Yujia Cai, Shanghai Jiao Tong University; Shen-Ying Zhang and Jean Laurent Casanova, Rockefeller University.
• External funding: The Lundbeck Foundation, the Danish National Research Foundation and the European Research Council (ERC)
• Direct link to the scientific article on which the media coverage is based: https://www.nature.com/articles/s41586-024-07670-z

Contact

Professor Søren Riis Paludan
Aarhus University, Department of Biomedicine
Telephone: +45 28 99 20 66
Email: srp@biomed.au.dk